HomeБез рубрикиOne step closer to eliminating latency, the real challenge in combating HIV
10Май
One step closer to eliminating latency, the real challenge in combating HIV
by
An international study led by MELIS-UPF researchers from the Infection Biology and Molecular Virology laboratories has identified and characterized Schlafen 12 (SLFN 12) as a novel HIV restriction factor. SLFN 12 shuts down viral protein production and helps virus-infected cells to escape from anti-HIV therapy and immune responses. These findings pave the way for improving therapeutic strategies that aim to cure HIV infections.